
RET-Positive Metastatic NSCLC
WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC
By
WCLC 2022 Conference Coverage
FEATURING
Motoko Tachihara
By
WCLC 2022 Conference Coverage
FEATURING
Motoko Tachihara
73 views
August 29, 2022
Comments 0
Login to view comments.
Click here to Login